120
VOLUME 11 NUMBER 3 • SEPTEMBER 2014
REVIEW
SA JOURNAL OF DIABETES & VASCULAR DISEASE
37. Gelfand M, Mavi S, Drummond RB, Ndemera B.
The Traditional Medical
Practitioner in Zimbabwe: His Principles of Practice and Pharmacopoeia
. Gweru,
Zimbabwe: Mambo Press, 1985.
38. Musabayane CT, Munjeri O, Mdege ND. Effects of Helichrysum ceres extracts on
renal function and blood pressure in the rat.
Renal Failure
2003;
25
: 5
Zimbabwe
14.
39. Musabayane CT, Kamadyaapa DR, Gondwe M, Moodley K, Ojewole JAO.
Cardiovascular effects of Helichrysum ceres S. Moore [Asteraceae] leaf ethanolic
extract in experimental animal paradigms.
Cardiovasc J Afr
2008;
19
(5): 246–253.
40. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic
nephropathy.
Nephron Physiol
2007;
106
: 26–31.
41. Yonekura H, Yamamoto Y, Sakurai S, Watanabe T, Yamamoto H. Roles of the
receptor for advanced glycation endproducts in diabetes-induced vascular injury.
J Pharmacol Sci
2005;
97
: 305–311.
42. Mason RM, Wahab NA. Extra-cellular matrix metabolism in diabetic nephropathy.
J Am Soc Nephrol
2003;
14
: 1358–1373.
43. Gruden G, Thomas S, Burt D, Lane S, Chusney G, Sacks S, Viberti G. Mechanical
stretch induces vascular permeability factor in human mesangial cells: Mechanisms
of signal transduction.
Proc Nat Acad Sci
(USA) 1997;
94
: 12112–12116.
44. Bickel CA, Knepper MA, Verbalis JG, Ecelbarger CA. Dysregulation of renal salt
and water transport proteins in diabetic Zucker rats.
Kidney Int Suppl
2002;
61
:
2099–2110.
45. Anderson S, Vora JP. Current concepts of renal hemodynamics in diabetes.
J
Diabetes Complications
1995;
9
: 304–307.
46. Ihara Y, Egashira K, Nakano K, Ohtani K, Kubo M, Koga J,
et al
. Upregulation of
the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the
pathogenesis of diabetic atherosclerosis.
J Mol Cell Cardiol
2007;
43
: 455–464.
47. Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R,
et al
. Accelerated
nephropathy in diabetic apolipoprotein E-knockout mouse: Role of advanced
glycation.
J Am Soc Nephrol
2004;
15
: 2125–2138.
48. Hartog JW, Voors AA, Bakker SJ, Smit AJ, van Veldhuisen DJ. Advanced glycation
end-products (AGEs) and heart failure: pathophysiology and clinical implications.
Eur J Heart Fail
2007;
9
: 1146–1155.
49. Tanaka Y, Uchino H, Shimizu T, Yoshii H, Niwa M, Ohmura C,
et al.
Effect of
metformin on advanced glycation endproduct formation and peripheral nerve
function in streptozotocin-induced diabetic rats.
Eur J Pharmacol
1999;
376
(1–2):
17–22.
50. Sheetz MJ, King GL. Molecular understanding of hyperglycaemia’s adverse effects
for diabetes complications.
J Am Med Assoc
2002;
288
: 2579–2588.
51. Rahbar S, Figarola JL. Novel inhibitors of advanced glycation endproducts.
Arch
Biochem Biophys
2003;
419
: 63–79.
52. Rahbar S, Yerneni KK, Scott S, Gonzales N, Lalezari I. Novel inhibitors of advanced
glycation endproducts (part II).
Mol Cell Biol Res Commun
2000;
3
(6): 360–366.
53. Kim H, Kang KS, Yamabe N, Nagai R, Yokozawa, T. Protective effect of heat-
processed American ginseng against diabetic renal damage in rats.
J Agric Food
Chem
2007;
55
: 8491–8497.
54. Kim JD, Kang SM, Park MY, Jung TY, Choi HY, Ku SW. Ameliorative anti-diabetic
activity of Dangnyosoko, a Chinese herbal medicine in diabetic rats.
Bioscience,
Biotechnol Biochem
2007;
71
(6): 1527–1534.
55. Kim SW, Jeon YS, Lee JU, Kang DG, Kook H, Ahn KY,
et al
. Diminished adenylate
cyclase activity and aquaporin 2 expression in acute renal failure rats.
Kidney Int
2000;
57
(4): 1239–1417.
56. Wirasathiena L, Pengsuparpa T, Suttisria R, Uedab H, Moriyasub M, Kawanishib
K. Inhibitors of aldose reductase and advanced glycation end-products formation
from the leaves of Stelechocarpus cauliflorus R.E. Fr.
Phytomedicine
2007;
14
:
546–550.
57. Atlas of End-Stage Renal Disease in the United States. Excerpts from the United
States Renal Data Systems 2002 annual report.
Am J Kidney Dis
2003;
41
(4):
S7–254.
58. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease.
With emphasis on the stage of incipient diabetic nephropathy.
Diabetes 32 Suppl
1983;
2
: 64–78.
59. Arije A, Kadiri S, Akinkugbe OO. The viability of hemodialysis as a treatment
option for renal failure in a developing economy.
Afr J Med Med Sci
2000;
29
:
311–314.
60. Marles R, Farnsworth N. Plants as sources of antidiabetic agents. In: Wagner H,
Farnsworth NR (eds).
Economic and Medicinal Plant Research.
UK: Academic
Press Ltd, 1994;
6
: 146–187.
61. Wang XM, Guan SH, Liu RX, Sun JH, Liang Y, Yang M, W
et al.
HPLC determination
of four triterpenoids in rat urine after oral administration of total triterpenoids
from Ganoderma lucidum .
J Pharmaceut Biomed Anal
2007;
43
: 1185–1190.
62. Nakagawa T, Goto H, Hikiami H, Yokozawa T, Shibahara N, Shimada Y. Protective
effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob
rats
J Ethnopharmacol
2007;
110
: 311–317.
63. Mapanga RF, Tufts MA, Shode FO, Musabayane CT. Renal effects of plant-derived
oleanolic acid in streptozotocin-induced diabetic rats.
Renal Failure
2009;
31
(6):
481–491.
64. Yokozawa T, Yamabe N, Kim HY, Kang KS, Hur JM, Park CH, Tanaka T. Protective
effects of morroniside isolated from Corni Fructus against renal damage in
streptozotocin-induced diabetic rats.
Biol Pharm Bull
2008;
31
: 1422–1428.
65. Rao NK, Nammi S. Antidiabetic and renoprotective effects of thechloroform
extract of Terminalia chebula Retz. Seeds in streptozotocininduced diabetic rats.
BMC Complement Alternative Med
2006;
6
: 17.
66. Musabayane C, Tufts MA, Mapanga RF. Synergistic antihyperglycemic effects
between plant-derived oleanolic acid and insulin in streptozotocin- induced
diabetic rats.
Renal Failure
2010;
32
: 832–839.
67. Al-Qattan K, Thomson M, Ali M. Garlic (Allium sativum) and ginger (Zingiber
officinale) attenuate structural nephropathy progression in streptozotocin-
induced diabetic rats.
Eur e-J Clin Nutr Metab
2008;
3
: e62–e71.
68. Eidi A, Eidi M, Esmaeili E. Antidiabetic effect of garlic (Allium sativum L.) in normal
and streptozotocin-induced diabetic rats.
Phytomedicine
2005;
13
: 624–629.
69. Ugochukwu NH, Cobourne MK. Modification of renal oxidative stress and lipid
peroxidation in streptozotocin-induced diabetic rats treated with extracts from
Gongronema latifolium leaves.
Clin Chim Acta
2003;
336
: 73–81.
70. El-Hilaly J, Hmammouchib M, Lyoussi B. Ethnobotanical studies and economic
evaluation of medicinal plants in Taounate province (Northern Morocco).
J
Ethnopharmacol
2003;
86
: 149–158
71. Tabassum M, Mumtaz M, Haleem MA. Electrolyte content of serum, erythrocyte,
kidney and heart tissue in salt induced hypertensive rats.
Life Sci
1996;
59
: 731–
747.
72. Bwititi P, Musabayane CT, Nhachi CFB. Effects of Opuntia megacantha on blood
glucose and kidney function in streptozotocin diabetic rats.
J Ethnopharmacol
2000;
69
(3): 247–252.
73. Bwititi PT, Machakaire T, Nhachi CB, Musabayane CT. Effects of Opuntia
megacantha leaves extract on renal electrolyte and fluid handling in streptozotocin
(STZ)-diabetic rats.
Renal Failure
2001;
23
: 149–158.
74. Prince PS, Menon VP, Pari L. Hypoglycaemic activity of Syzigium cumini seeds:
effect on lipid peroxidation in alloxandiabetic rats.
J Ethnopharmacol
1998;
61
:
l–7.
75. Braca A, Politi M, Sanogo R, Sanou H, Morelli I, Pizza CN. Chemical composition
and antioxidant activity of phenolic compounds from wild and cultivated
Sclerocarya birrea(Anacardiaceae) leaves.
J Agric Food Chem
2003;
51
(23):
6689–6695.
76. Afzal M, KhanNA, GhufranA, Iqbal A, InamuddinM. Diuretic and nephroprotective
effect of Jawarish Zarooni Sada – a polyherbal unani formulation.
J Ethnopharmacol
2004;
91
(2–3): 219–223.
77. Yasir M, Das S, Kharya MD. The phytochemical and pharmacological profile of
Persea americana
Mill. Phcog Rev
2010;
4
: 77–84.
78. Owolabi MA, Coker HAB, Jaja SI. Bioactivity of the phytoconstituents of the
leaves of Persea americana.
Journal of Medicinal Plants Research
2010;
4
(12):
1130–1135.
79. Musabayane CT, Xozwa K, Ojewole JAO. Effects of
Hypoxis hemerocallidea
(Fisch.
& C.A. Mey) [Hypoxidaceae] corm (African Potato) aqueous extract on renal
electrolyte and fluid handling in the rat.
Renal Failure
2005;
27
(5): 763–770.
80. Ojewole JAO. Antinociceptive, anti-inflammatory and antidiabetic properties of
Hypoxis hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) corm [African Potato]
aqueous extract in mice and rats.
J Ethnopharmacol
2006;
103
(1): 126–134.
81. Usman H, Abdulrahman F, Usman A. Qualitative phytochemical screening and
in vitro
antimicrobial effects of methanol stem bark extract of
Ficus thonningii
(Moraceae).
Afr J Tradit Complement Altern Med
2009;
6
(3): 289–295.
82. Benavente-Garcia O, Castillo J, Lorente J, Ortuno A, Del Rio JA. Antioxidant
activity of phenolics extracted from
Olea europaea
L. leaves Food Chem 2000;
68
: 457–462.
83. Bennani-Kabchi N, Fdhil H, Cherrah Y, El Bouayadi F, Kehel L, Marquie G.
Therapeutic effect of Olea europea var. oleaster leaves on carbohydrate and lipid
metabolism in obese and prediabetic sand rats (Psammomys obesus)
Ann Pharm
Fr
2000;
58
: 271–277.
84. Al-Azzawie HF, Alhamdani MS. Hypoglycemic and antioxidant effect of oleuropein
in alloxan-diabetic rabbits
Life Sci
2006;
78
: 1371–1377.
85. Fitzpatrick DF, Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent
vasorelaxation caused by various plant extracts.
J Cardiovas Pharmacol
1995;
26
:
90–95.
